デフォルト表紙
市場調査レポート
商品コード
1713715

動物用分子診断の世界市場レポート 2025年

Veterinary Molecular Diagnostics Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.00円
動物用分子診断の世界市場レポート 2025年
出版日: 2025年04月23日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物用分子診断市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.7%で10億1,000万米ドルに成長します。予測期間における成長は、コンパニオンアニマルの導入増加、ペット保険の導入増加、ペット数の増加、動物ヘルスケア支出の増加、動物診断検査需要の増加に起因しています。予測期間の主な動向には、獣医分子診断技術の技術的進歩、高度なラボ装置、PCR、次世代シーケンシング(NGS)、マイクロアレイ技術の進歩などの技術的進歩が含まれます。

人獣共通感染症の高い流行が動物用分子診断市場の成長を促進すると予想されます。人獣共通感染症は、動物と人間の間で感染する可能性があり、細菌、ウイルス、寄生虫、または真菌によって引き起こされます。狂犬病、ライム病、サルモネラ症、トキソプラズマ症などがその例です。これらの病気が蔓延する要因としては、森林伐採、野生生物の搾取、集約的畜産、生物多様性の損失、人間の移動の増加などが挙げられます。動物用分子診断は、動物における人獣共通感染症の早期発見を可能にすることで重要な役割を果たし、ヒトへの感染を防ぐとともに、迅速かつ正確な病原体の特定を通じて疾病管理を改善します。例えば、2024年2月に英国政府が発表した報告書によると、イングランドにおけるライム病患者は、2022年第4四半期の273人から2023年同期には335人に増加しました。このような人獣共通感染症の流行増加は、動物用分子診断の需要を煽っています。

動物用分子診断市場の主要企業は、大量検査機などの診断技術の自動化と拡張性に注力しています。これらの先進的な装置は、大量の検体を効率的に処理するように設計されており、診断の精度とスピードが向上しています。例えば、2023年6月、アイオワ州立大学の獣医診断研究所(VDL)は、定量ポリメラーゼ連鎖反応(qPCR)技術を搭載した最先端の分子診断検査装置SmartChipを発表しました。SmartChipは切手サイズのプレートで5,000検体以上を処理でき、自動処理機能を備えた384検体システムと組み合わせて使用します。マイクロ流体技術を活用したSmartChipは、VDLの標準96ウェル装置より100倍小さい容積でサンプル中のターゲットを同定します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の動物用分子診断PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の動物用分子診断市場:成長率分析
  • 世界の動物用分子診断市場の実績:規模と成長, 2019-2024
  • 世界の動物用分子診断市場の予測:規模と成長, 2024-2029, 2034F
  • 世界の動物用分子診断総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の動物用分子診断市場:製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • キットと試薬
  • 機器
  • 世界の動物用分子診断市場動物の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • コンパニオンアニマル
  • 家畜
  • 世界の動物用分子診断市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 感染症
  • 遺伝性疾患
  • その他の用途
  • 世界の動物用分子診断市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 診断検査室
  • 獣医クリニック
  • 動物病院
  • その他のエンドユーザー
  • 世界の動物用分子診断市場キットと試薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ポリメラーゼ連鎖反応(PCR)キット
  • 逆転写PCR(RT-PCR)キット
  • リアルタイムPCRキット
  • 核酸抽出キット
  • 酵素免疫測定(ELISA)キット
  • ハイブリダイゼーションキット
  • 次世代シーケンシング(NGS)用試薬
  • 世界の動物用分子診断市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • PCRマシン(サーマルサイクラー)
  • リアルタイムPCR装置
  • 核酸分析装置
  • ゲル電気泳動装置
  • DNAシーケンサー
  • 自動液体処理システム
  • 分子イメージングシステム

第7章 地域別・国別分析

  • 世界の動物用分子診断市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の動物用分子診断市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 動物用分子診断市場:競合情勢
  • 動物用分子診断市場:企業プロファイル
    • Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • PerkinElmer Inc.
  • bioMerieux S.A.
  • IDEXX Laboratories Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN N.V.
  • LGC Group Ltd.
  • Neogen Corporation
  • Abcam plc
  • Eiken Chemical Co. Ltd.
  • Bioneer Corporation
  • INDICAL BIOSCIENCE GmbH
  • Biochek B.V.
  • Ring Biotechnology Co. Ltd.
  • Ingenetix GmbH
  • MiDOG Animal Diagnostics LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 動物用分子診断市場2029:新たな機会を提供する国
  • 動物用分子診断市場2029:新たな機会を提供するセグメント
  • 動物用分子診断市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33617

Veterinary molecular diagnostics involves the use of molecular biology techniques to identify and diagnose animal diseases at the genetic or molecular level. These diagnostics detect specific pathogens (such as bacteria, viruses, or parasites), genetic mutations, or biomarkers that signal disease, assisting veterinarians in making precise diagnoses and treatment plans.

The main products in veterinary molecular diagnostics include kits, reagents, and instruments. Kits and reagents are crucial for conducting various diagnostic tests on animal samples in laboratories and industrial settings, providing accurate and reliable results necessary for effective treatment and management of diseases. These diagnostics are applicable to both companion animals and livestock, addressing conditions such as infectious and genetic diseases. The primary users of these products are diagnostic laboratories, veterinary clinics, veterinary hospitals, and similar facilities.

The veterinary molecular diagnostics market research report is one of a series of new reports from the business research company that provides veterinary molecular diagnostics market statistics, including veterinary molecular diagnostics industry global market size, regional shares, competitors with an veterinary molecular diagnostics market share, detailed veterinary molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary molecular diagnostics industry. This veterinary molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary molecular diagnostics market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.7 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to the high prevalence of zoonotic and foodborne diseases, rising adoption of multiple testing panels, growing consolidation in the veterinary diagnostics industry, increased animal health spending, and rising demand for animal-derived food.

The veterinary molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising adoption of companion animals, increasing adoption of pet insurance, rising pet population, increasing animal healthcare expenditure, and increasing demand for animal diagnostic tests. Major trends in the forecast period include technological advancements in veterinary molecular diagnostic technologies, advanced laboratory devices, technological advancements such as PCR, next-generation sequencing (NGS), and microarray technological advancements.

The high prevalence of zoonotic diseases is expected to drive growth in the veterinary molecular diagnostics market. Zoonotic diseases, which can be transmitted between animals and humans, are caused by bacteria, viruses, parasites, or fungi. Examples include rabies, Lyme disease, salmonellosis, and toxoplasmosis. Factors contributing to the prevalence of these diseases include deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and increased human mobility. Veterinary molecular diagnostics play a crucial role by enabling early detection of zoonotic diseases in animals, which helps prevent their transmission to humans and improves disease management through rapid and accurate pathogen identification. For example, a February 2024 report from the Government of the United Kingdom revealed that Lyme disease cases in England increased from 273 in the fourth quarter of 2022 to 335 in the same period of 2023. This rising prevalence of zoonotic diseases is fueling demand for veterinary molecular diagnostics.

Leading companies in the veterinary molecular diagnostics market are focusing on automation and scalability in diagnostic technologies, such as high-volume testing machines. These advanced devices are designed to process large numbers of samples efficiently, enhancing diagnostic accuracy and speed. For instance, in June 2023, Iowa State University's Veterinary Diagnostic Laboratory (VDL) introduced the SmartChip, a state-of-the-art molecular diagnostic testing device featuring quantitative polymerase chain reaction (qPCR) technology. The SmartChip can handle over 5,000 samples on a plate the size of a postage stamp and is paired with a 384-sample system that includes automated handling features. Utilizing microfluidic technology, the SmartChip identifies targets in samples using a volume 100 times smaller than that of the VDL's standard 96-well machines.

In June 2022, R-Biopharm AG, a biotechnology company based in Germany, acquired AusDiagnostics. This acquisition expands R-Biopharm AG's molecular diagnostics portfolio, enhances its role as a comprehensive system supplier, and fosters growth in the clinical diagnostics market. AusDiagnostics, an Australian company, specializes in molecular biology multiplex diagnostics solutions.

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMerieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

North America was the largest region in the Veterinary Molecular Diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary molecular diagnostics market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance testing, genetic testing, toxicology, and biocompatibility testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary molecular diagnostics market also includes sales of immunoassay kits, diagnostic software, and next-generation sequencing (NGS) systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Kits And Reagents; Instrument
  • 2) By Animal Type: Companion Animals; Livestock Animals
  • 3) By Application: Infectious Diseases; Genetic Diseases; Other Applications
  • 4) By End-User: Diagnostic Laboratories; Veterinary Clinics; Veterinary Hospitals; Other End-Users
  • Subsegments:
  • 1) Kits and Reagents: Polymerase Chain Reaction (PCR) Kits; Reverse Transcription PCR (RT-PCR) Kits; Real-Time PCR Kits; Nucleic Acid Extraction Kits; Enzyme-linked Immunosorbent Assay (ELISA) Kits; Hybridization Kits; Reagents for Next-Generation Sequencing (NGS)
  • 2) Instruments: PCR Machines (Thermal Cyclers); Real-Time PCR Machines; Nucleic Acid Analyzers; Gel Electrophoresis Equipment; DNA Sequencers; Automated Liquid Handling Systems; Molecular Imaging Systems
  • Companies Mentioned: Roche Diagnostics Corporation; Thermo Fisher Scientific Inc.; Merck KGaA; Zoetis Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Molecular Diagnostics Market Characteristics

3. Veterinary Molecular Diagnostics Market Trends And Strategies

4. Veterinary Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Veterinary Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Veterinary Molecular Diagnostics Market Growth Rate Analysis
  • 5.4. Global Veterinary Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Veterinary Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Veterinary Molecular Diagnostics Total Addressable Market (TAM)

6. Veterinary Molecular Diagnostics Market Segmentation

  • 6.1. Global Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits And Reagents
  • Instrument
  • 6.2. Global Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Companion Animals
  • Livestock Animals
  • 6.3. Global Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Diseases
  • Genetic Diseases
  • Other Applications
  • 6.4. Global Veterinary Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Laboratories
  • Veterinary Clinics
  • Veterinary Hospitals
  • Other End-Users
  • 6.5. Global Veterinary Molecular Diagnostics Market, Sub-Segmentation Of Kits and Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR) Kits
  • Reverse Transcription PCR (RT-PCR) Kits
  • Real-Time PCR Kits
  • Nucleic Acid Extraction Kits
  • Enzyme-linked Immunosorbent Assay (ELISA) Kits
  • Hybridization Kits
  • Reagents for Next-Generation Sequencing (NGS)
  • 6.6. Global Veterinary Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Machines (Thermal Cyclers)
  • Real-Time PCR Machines
  • Nucleic Acid Analyzers
  • Gel Electrophoresis Equipment
  • DNA Sequencers
  • Automated Liquid Handling Systems
  • Molecular Imaging Systems

7. Veterinary Molecular Diagnostics Market Regional And Country Analysis

  • 7.1. Global Veterinary Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Veterinary Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Molecular Diagnostics Market

  • 8.1. Asia-Pacific Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Molecular Diagnostics Market

  • 9.1. China Veterinary Molecular Diagnostics Market Overview
  • 9.2. China Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Molecular Diagnostics Market

  • 10.1. India Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Molecular Diagnostics Market

  • 11.1. Japan Veterinary Molecular Diagnostics Market Overview
  • 11.2. Japan Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Molecular Diagnostics Market

  • 12.1. Australia Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Molecular Diagnostics Market

  • 13.1. Indonesia Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Molecular Diagnostics Market

  • 14.1. South Korea Veterinary Molecular Diagnostics Market Overview
  • 14.2. South Korea Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Molecular Diagnostics Market

  • 15.1. Western Europe Veterinary Molecular Diagnostics Market Overview
  • 15.2. Western Europe Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Molecular Diagnostics Market

  • 16.1. UK Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Molecular Diagnostics Market

  • 17.1. Germany Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Molecular Diagnostics Market

  • 18.1. France Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Molecular Diagnostics Market

  • 19.1. Italy Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Molecular Diagnostics Market

  • 20.1. Spain Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Molecular Diagnostics Market

  • 21.1. Eastern Europe Veterinary Molecular Diagnostics Market Overview
  • 21.2. Eastern Europe Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Molecular Diagnostics Market

  • 22.1. Russia Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Molecular Diagnostics Market

  • 23.1. North America Veterinary Molecular Diagnostics Market Overview
  • 23.2. North America Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Molecular Diagnostics Market

  • 24.1. USA Veterinary Molecular Diagnostics Market Overview
  • 24.2. USA Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Molecular Diagnostics Market

  • 25.1. Canada Veterinary Molecular Diagnostics Market Overview
  • 25.2. Canada Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Molecular Diagnostics Market

  • 26.1. South America Veterinary Molecular Diagnostics Market Overview
  • 26.2. South America Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Molecular Diagnostics Market

  • 27.1. Brazil Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Molecular Diagnostics Market

  • 28.1. Middle East Veterinary Molecular Diagnostics Market Overview
  • 28.2. Middle East Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Molecular Diagnostics Market

  • 29.1. Africa Veterinary Molecular Diagnostics Market Overview
  • 29.2. Africa Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Veterinary Molecular Diagnostics Market Competitive Landscape
  • 30.2. Veterinary Molecular Diagnostics Market Company Profiles
    • 30.2.1. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Molecular Diagnostics Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. bioMerieux S.A.
  • 31.3. IDEXX Laboratories Inc.
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. QIAGEN N.V.
  • 31.6. LGC Group Ltd.
  • 31.7. Neogen Corporation
  • 31.8. Abcam plc
  • 31.9. Eiken Chemical Co. Ltd.
  • 31.10. Bioneer Corporation
  • 31.11. INDICAL BIOSCIENCE GmbH
  • 31.12. Biochek B.V.
  • 31.13. Ring Biotechnology Co. Ltd.
  • 31.14. Ingenetix GmbH
  • 31.15. MiDOG Animal Diagnostics LLC

32. Global Veterinary Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Molecular Diagnostics Market

34. Recent Developments In The Veterinary Molecular Diagnostics Market

35. Veterinary Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Veterinary Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Veterinary Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Veterinary Molecular Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33617_Veterinary_Molecular_Diagnostics_GMR_2025